Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Acta Tropica, 3(102), p. 206-211, 2007

DOI: 10.1016/j.actatropica.2007.05.002

Links

Tools

Export citation

Search in Google Scholar

Evaluation of the EIE-IgM Leptospirose assay for the serodiagnosis of leptospirosis

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Access to low-cost, effective diagnosis for leptospirosis is urgently needed in developing countries. The EIE-IgM-Leptospirose, a kit produced for public health laboratories in Brazil, was shown to have a sensitivity of 76% (77 of 102 patients) and 100% (102 of 102 patients) during acute and convalescent-phase leptospirosis, respectively, and a specificity of 93-100% (total healthy and patient control subjects evaluated, 486). These findings indicate that the assay will be useful for diagnosis of this emerging infectious disease in Brazil and other developing countries.